Hyphens Pharma net profit grows to $10.76m in 2024

Revenue also jumped 14.6% for the year.

Hyphens Pharma International Limited saw its total comprehensive income attributable rise to $10.76m in the full year ended 31 December 2024 up from $8.38m in the same period last year.

Revenue for the year reached a record of $195.4m up 14.6% from the previous year. The revenue jump was mostly attributed to to a 21.6% jump by the Specialty Pharma Principals business.

Meanwhile, the Proprietary Brands segment’s revenue grew by 7.4%, boosted by higher demand for Ceradan dermatological products, Ocean Health health supplement products, TDF dermocosmetic products and Novem nutraceutical products. Lastly, revenue from the Medical Hypermart and Digital segment also saw a modest increase of 2.1%.

Gross profit increased by 12.3% to S$69.5 million in FY2024, in tandem with increased sales. However, the gross profit margin decreased marginally from 36.3% in FY2023 to 35.6% in FY2024 due to an increase in the cost of sales from the principals and suppliers.

The group’s newly acquired Ardence Pharma Sdn Bhd contributed $7.2m in revenue.

Hyphens Pharma is proposing a final dividend of 1.50 Singapore cents per share for FY2024.

Follow the link for more news on

pharmaceuticals

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia